2-indanylamino derivatives for the therapy of chronic pain

Details for Australian Patent Application No. 2002366727 (hide)

Owner Chiesi Farmaceutici S.p.A.

Inventors Pietra, Claudio; Villetti, Gino

Agent Lord and Company

Pub. Number AU-B-2002366727

PCT Number PCT/EP02/13839

PCT Pub. Number WO2003/053429

Priority 01130638.8 21.12.01 EP

Filing date 6 December 2002

Wipo publication date 9 July 2003

Acceptance publication date 19 April 2007

International Classifications

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/198 (2006.01)

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

Event Publications

28 August 2003 Complete Application Filed

  Priority application(s): 01130638.8 21.12.01 EP

2 October 2003 Application Open to Public Inspection

  Published as AU-B-2002366727

19 April 2007 Application Accepted

  Published as AU-B-2002366727

16 August 2007 Standard Patent Sealed

5 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002366728-SURFACE MODIFIED ZINC OXIDE FOR THE PRODUCTION OF NANOPARTICULATE DISPERSIONS

2002366726-PROCESS FOR THE CONTINUOUS QUATERNISATION OF TERTIARY AMINES WITH AN ALKYL HALIDE